Insider filing · ANIP
Thomas Haughey
Director
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 50 filings in 24 months
ticker →
Thomas Haughey sold $1.7M of ANI Pharmaceuticals (ANIP)
Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.
Value, as filed
$1.7M
19,341 sh × $85.93
Executed
Aug 12 2025
the trade date, as filed
Disclosed
Aug 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
THThomas Haughey (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $162K of ANIP (2,000 sh × $80.88, as filed), executed Jun 8.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Thomas Haughey in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$162K2,000 sh × $80.88
Exec Jun 8
Filed Jun 10 · 5:30 PM ET